Lecheng special access (pre-NMPA drugs & devices)
乐城特许药械通道
Treats: Oncology & rare disease products approved by FDA/EMA/PMDA but not yet NMPA
At a glance
Catalogue items
485+
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
- en.hainan.gov.cn 2026-06
Official / government source
Institutions
36
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
- en.hainan.gov.cn 2026-06
Official / government source
Overseas patients (2025)
14
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
- hicn.cn (hiHainan)
Secondary source (media / community / commercial)
Verified cost data
Verified pricing is not currently available.
How China compares internationally
International comparison
Access play: only place in mainland China to use these products legally
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
NotesReported comparison, not independently verified.
Eligibility depends on diagnosis, disease status, prior treatment, and clinical assessment. This page is general information, not medical advice.
Sources & verification
- en.hainan.gov.cn 2026-06 — Official / government source
- hicn.cn (hiHainan) — Secondary source (media / community / commercial)
Reader discussion
Public comments about Lecheng special access (pre-NMPA drugs & devices). Discussion is not medical advice, and a comment is not an endorsement or a verified fact. Open the full forum.